Gale, Richard
Cox, Oliver http://orcid.org/0000-0002-2308-7837
Keenan, Craig
Chakravarthy, Usha http://orcid.org/0000-0002-2606-3734
Funding for this research was provided by:
Roche
Article History
Received: 29 April 2022
Revised: 13 May 2022
Accepted: 14 June 2022
First Online: 28 June 2022
Competing interests
: CK is an employee of PHMR LTD, who received consulting fees from F. Hoffmann-La Roche AG. OC is an employee of F. Hoffmann-La Roche AG. UC has conducted consultancy-advisory boards for Bayer, Novartis, Roche; Grants—National Institute of Health Research; and is Visiting Professor at F. Hoffman-La Roche, Basel, Switzerland. RG has acted as a consultant, or is on the speaker’s bureau, for Novartis, Bayer, Allergan/Abbvie, Roche, Almeria, Heidelberg, Boehringer Ingelheim, Notal Vision, Santen.